FERI (Luxembourg) S.A.’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.08M Buy
34,050
+1,670
+5% +$234K 0.68% 41
2026
Q2
$4.09M Sell
32,380
-6,340
-16% -$835K 0.65% 43
2026
Q1
$5.4M Buy
38,720
+8,930
+30% +$1.25M 1.05% 24
2025
Q4
$3.66M Sell
29,790
-2,410
-7% -$293K 0.81% 35
2025
Q3
$3.57M Buy
32,200
+12,700
+65% +$1.44M 1.04% 30
2025
Q2
$2.16M Sell
19,500
-7,000
-26% -$745K 0.69% 43
2025
Q1
$2.97M Buy
26,500
+5,406
+26% +$558K 1.03% 27
2024
Q4
$1.95M Buy
21,094
+554
+3% +$49.9K 1.08% 20
2024
Q3
$1.72M Buy
+20,540
New +$1.57M 0.98% 21
2024
Q2
– Sell
-8,620
Closed -$631K – 104
2024
Q1
$631K Sell
8,620
-7,620
-47% -$586K 0.45% 76
2023
Q4
$1.32M Buy
+16,240
New +$1.26M 0.97% 31

Other funds holding GILD

FERI (Luxembourg) S.A.'s GILD Position: Q3 2026 in Review

FERI (Luxembourg) S.A. increased its Gilead Sciences (GILD) stake by 5.2% in Q3 2026, buying an estimated $234K and bringing the position to 34,050 shares worth $5.08M. The position accounts for 0.68% of the portfolio, ranked #41.

FERI (Luxembourg) S.A. first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.4M in Q1 2026. 2,209 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • FERI (Luxembourg) S.A. held 34,050 shares of Gilead Sciences worth $5.08M as of Q3 2026.
  • FERI (Luxembourg) S.A. bought 1,670 Gilead Sciences shares in Q3 2026, an estimated $234K.
  • Gilead Sciences made up 0.68% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #41 holding.
  • FERI (Luxembourg) S.A. first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • FERI (Luxembourg) S.A.'s Gilead Sciences position peaked at $5.4M in Q1 2026.
  • 2,209 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.